Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Liquidia Technologies (LQDA) and Pacific Biosciences (PACB)

TipRanksMay 15 01:10

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Iovance Biotherapeutics (IOVA) and Intellia Therapeutics (NTLA)

TipRanksMay 14 17:20

Intellia Therapeutics Is Maintained at Neutral by Citigroup

Intellia Therapeutics Is Maintained at Neutral by Citigroup

Dow JonesMay 11 05:44

Citi: Maintains Intellia Therapeutics (NTLA.US) rating, adjusted from neutral to neutral, and adjusted the target price from $31.00 to $29.00.

Citi: Maintains Intellia Therapeutics (NTLA.US) rating, adjusted from neutral to neutral, and adjusted the target price from $31.00 to $29.00.

Zhitong FinanceMay 11 05:40

Citigroup Maintains Neutral on Intellia Therapeutics, Lowers Price Target to $29

Citigroup analyst David Lebowitz maintains Intellia Therapeutics (NASDAQ:NTLA) with a Neutral and lowers the price target from $31 to $29.

BenzingaMay 11 05:34

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 11 03:35